Publications by authors named "David C Fritzinger"

Claim this Profile
I
Identification of intermolecular bonds between human factor B and Cobra Venom Factor important for C3 convertase stability.
Brian E Hew, Michael K Pangburn, Carl-Wilhelm Vogel, David C Fritzinger

Toxicon· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of functionally important amino acid sequences in cobra venom factor using human C3/Cobra venom factor hybrid proteins.
Brian E Hew, David C Fritzinger, Michael K Pangburn, Carl-Wilhelm Vogel

Toxicon· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absence of a neutralizing antibody response to humanized cobra venom factor in mice.
Mathieu Ing, Brian E Hew, David C Fritzinger, Sandrine Delignat, Sébastien Lacroix-Desmazes

Mol Immunol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complement C3 is a novel modulator of the anti-factor VIII immune response.
Julie Rayes, Mathieu Ing, Sandrine Delignat, Ivan Peyron, Laurent Gilardin, David C Fritzinger

Haematologica· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Complement System in Neuropathic and Postoperative Pain.
David C Fritzinger, Daniel E Benjamin

Open Pain J· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complement depletion with humanised cobra venom factor: efficacy in preclinical models of vascular diseases.
Carl-Wilhelm Vogel, David C Fritzinger, W Brian Gorsuch, Gregory L Stahl

Thromb Haemost· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humanized cobra venom factor: structure, activity, and therapeutic efficacy in preclinical disease models.
Carl-Wilhelm Vogel, Paul W Finnegan, David C Fritzinger

Mol Immunol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hybrid proteins of Cobra Venom Factor and cobra C3: tools to identify functionally important regions in Cobra Venom Factor.
Brian E Hew, Daniel Wehrhahn, David C Fritzinger, Carl-Wilhelm Vogel

Toxicon· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complement depletion with humanized cobra venom factor in a mouse model of age-related macular degeneration.
David C Fritzinger, Robin Dean, Carol Meschter, Katina Wong, Roman Halter

Adv Exp Med Biol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cobra venom factor: Structure, function, and humanization for therapeutic complement depletion.
Carl-Wilhelm Vogel, David C Fritzinger

Toxicon· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humanized cobra venom factor decreases myocardial ischemia-reperfusion injury.
W Brian Gorsuch, Benjamin J Guikema, David C Fritzinger, Carl-Wilhelm Vogel, Gregory L Stahl

Mol Immunol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Depletion of the C3 component of complement enhances the ability of rituximab-coated target cells to activate human NK cells and improves the efficacy of monoclonal antibody therapy in an in vivo model.
Siao-Yi Wang, Suresh Veeramani, Emilian Racila, Jeffrey Cagley, David C Fritzinger

Blood· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insights into complement convertase formation based on the structure of the factor B-cobra venom factor complex.
Bert J C Janssen, Lucio Gomes, Roman I Koning, Dmitri I Svergun, Abraham J Koster, David C Fritzinger

EMBO J· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional characterization of human C3/cobra venom factor hybrid proteins for therapeutic complement depletion.
David C Fritzinger, Brian E Hew, Mike Thorne, Michael K Pangburn, Bert J C Janssen

Dev Comp Immunol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Derivatives of human complement component C3 for therapeutic complement depletion: a novel class of therapeutic agents.
David C Fritzinger, Brian E Hew, June Q Lee, James Newhouse, Maqsudul Alam

Adv Exp Med Biol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humanized cobra venom factor: experimental therapeutics for targeted complement activation and complement depletion.
Carl-Wilhelm Vogel, David C Fritzinger

Curr Pharm Des· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer research center hotline: complement depletion: use of human C3/cobra venom factor (CVF) chimeric proteins as therapeutic agents.
David C Fritzinger

Hawaii Med J· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure and function of recombinant cobra venom factor.
Michael A Kock, Brian E Hew, Holger Bammert, David C Fritzinger, Carl-Wilhelm Vogel

J Biol Chem· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant cobra venom factor.
Carl-Wilhelm Vogel, David C Fritzinger, Brian E Hew, Mike Thorne, Holger Bammert

Mol Immunol· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis